The Estée Lauder Companies Opens Global Fragrance Atelier in Paris, Accelerating Next-Generation Innovation in Perfume Artistry
14.10.2025 07:00:00 CEST | Business Wire | Press Release
The Estée Lauder Companies Inc. (NYSE:EL), under the High Patronage of Mr. Emmanuel Macron, President of the French Republic,today announced the opening of its Fragrance Atelier within its new La Maison des Parfums on Rue Volney in Paris. This newly established global innovation hub is fully dedicated to world-class fragrance expertise, advanced technologies and cutting-edge capabilities, and will accelerate the company’s strategic ambitions in luxury and prestige fragrances. Rooted in the legacy of Mrs. Estée Lauder’s pioneering vision and her lifelong passion for fragrance, the Atelier’s opening marks a significant milestone in the company’s longstanding commitment to fragrance excellence and craftsmanship.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251013447078/en/
The Exterior of La Maison des Parfums
“It is with great pride and excitement that we open our Fragrance Atelier in Paris,” said Stéphane de La Faverie, President and Chief Executive Officer, The Estée Lauder Companies. “Building on our incredible heritage of creativity and innovation, the Atelier will propel our future growth in this dynamic category — uniting world-class expertise, cutting-edge technology, and the artistry of fragrance to accelerate innovation across our portfolio. Located in the cradle of perfumery, our teams will blend state-of-the-art technology, data-driven intelligence, and olfactive expertise to craft the next generation of extraordinary scents for our consumers worldwide.”
“The Fragrance Atelier is an exciting new model for creation — a space that harnesses creativity and science to shape the future of fragrance,” said René Lammers, The Estée Lauder Companies’ Chief Research & Innovation Officer. “This hub brings together experts from across our fragrance brands and partners in an environment purpose-built for experimentation. Together, they will accelerate the journey from inspiration to formulation and ultimately to the final consumer experience.”
A Bold Addition to The Estée Lauder Companies’ Innovation Network
The Atelier further enhances The Estée Lauder Companies’ global research and innovation network across the United States (New York and Minnesota), China (Shanghai), Europe (Belgium), and Canada (Toronto). Together, these sites seamlessly integrate category- and region-specific strengths to drive breakthrough discovery across the full spectrum of beauty. The Atelier introduces an AI-enabled, end-to-end creation process that combines olfactive and neuroscience modeling with real-time monitoring of patents, research, and regulations. These resources will accelerate discovery, develop new technologies, fuel experimentation, and enable faster response to evolving consumer trends, reducing fragrance development lead times by up to 30–50% in the coming years.
A Transformative Space Custom Built for Fragrance Innovation
Inside the Atelier, specialized co-creation and innovation spaces bring artistry and science to life. In the Music Room, perfumers from leading fragrance houses and brand teams collaborate to compose signature accords and explore new olfactive territories. In the adjoining laboratories, experts use CO₂ supercritical extraction, GCMS molecule analysis, and AI-driven sillage measurement to understand fragrance structure and longevity at the molecular level. Proprietary neuroscience-based consumer modeling transforms sensory data into insight, helping creators design fragrances that stir emotion and inspire desire.
Serving as a shared innovation engine for all fragrance brands within the company’s portfolio, the Atelier accelerates collaboration and discovery across Jo Malone London, TOM FORD, Le Labo, KILIAN PARIS, and Editions de Parfums Frédéric Malle, as well as across Estée Lauder, Clinique, AERIN Beauty, Aramis, and BALMAIN Beauty fragrances. Each brand retains its distinctive voice while drawing on shared access to next-generation technology, proprietary ingredients, and scientific expertise.
Located in the heart of Paris, La Maison des Parfums unites the company’s fragrance, creative, and innovation teams within a five-story, 2,000-square-meter space that blends French craftsmanship with modern design. Its architecture evokes the composition of a fragrance — travertine as the base, artisanal details as the heart, and light-infused finishes as the top note — creating an immersive environment where heritage and innovation coexist in harmony.
Deepening The Estée Lauder Companies’ Commitment to France
The Atelier’s opening underscores The Estée Lauder Companies’ enduring commitment to France, a country whose strong culture of innovation and investment continues to make it a vital strategic market and creative hub for the company. The company’s presence in France spans nearly six decades, beginning with its first French office in 1966. Today, Paris serves as the location for the company’s EUKEM regional headquarters, a newly created geographic cluster encompassing Europe, the United Kingdom and Ireland, and emerging markets in Asia, Africa and the Middle East, as well as the headquarters of the company’s French sales affiliate.
The Estée Lauder Companies employs more than 1,200 people in France and proudly operates the global headquarters of several of its brands there, including KILIAN PARIS, Editions de Parfums Frédéric Malle, Darphin Paris, and Lab Series. The establishment of La Maison des Parfums and the Fragrance Atelier builds on this foundation, further connecting the company to France’s world-renowned ecosystem of perfumers, suppliers, and creative talent.
“We are extremely proud that The Estée Lauder Companies has chosen France as the location for its new Fragrance Atelier — an innovative project announced at the most recent Choose France summit,” said Pascal Cagni, French Ambassador for International Investments and Chairman of the Board of Business France. “Their choice demonstrates the confidence that international leaders have in French excellence, which is driven by a unique ecosystem of creative talent, innovation, and globally recognized expertise. The French perfume and cosmetics industry, with more than €30 billion in revenue, is a key driver of growth and attractiveness. The Estée Lauder Companies’ Fragrance Atelier is a perfect demonstration of France’s ability to offer companies an environment conducive to the development of their most ambitious projects. I commend the remarkable work of the Business France teams which enables France to remain at the forefront of the global perfume industry.”
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include those in the various quotations. Although the Company believes that its expectations are based on reasonable assumptions within the bounds of its knowledge of its business and operations, actual results may differ materially from the Company’s expectations. Factors that could cause actual results to differ from expectations include the ability to successfully implement the Company’s strategy, including Beauty Reimagined and the profit recovery and growth plan; successfully transition its leadership; and those other factors described in the Company’s filings with the Securities and Exchange Commission, including its most recent filings with the Securities and Exchange Commission. The Company assumes no responsibility to update forward-looking statements made herein or otherwise.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251013447078/en/
Contacts
Media Relations:
Lauren Pratapas
lpratapa@estee.com
Investor Relations:
Rainey Mancini
rmancini@estee.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
Digital Reef Turns to Vertical Farming to Reduce Data Centre Footprint in Partnership With Elevate Farms and Xange.com to Provide Digital Measurement, Reporting and Verification of Project's Environmental Impact Within the Reef Origin Ecosystem23.10.2026 13:12:00 CEST | Press Release
Elevate Farms Inc. and Digital Reef Ltd partnership supports mitigating environmental impact of global data centre expansion establishing a framework for Digital Reef’s infrastructure pipeline to support and utilize environmental assets generated by Elevate Farms' high-yield, closed-loop vertical farming operations. Traditional agriculture supply chains are replaced with optimized indoor facilities significantly reducing food production carbon emissions, water waste and local land constraints. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022393352/en/ Elevate Farms technology offers part of the solution to climate impact isolating food production from traditional agricultural farming variables saving over 95% of standard water requirements and significantly reducing farmland required for equivalent yields and logistical carbon. Digital Reef CEO Piers Slater stated "Digital Reef embrace data centre growth and environment
SLB Announces Third-Quarter 2026 Results23.10.2026 12:50:00 CEST | Press Release
SLB (NYSE: SLB) today announced results for the third-quarter 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261021694458/en/ The exterior of the SLB headquarters in Houston, Texas. Third-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2026Jun. 30, 2026Sept. 30, 2025SequentialYear-on-yearRevenue $9,449 $8,972 $8,928 5% 6% Income before taxes - GAAP basis $1,019 $1,018 $1,000 0% 2% Income before taxes margin - GAAP basis 10.8% 11.4% 11.2% -57 bps -42 bps Net income attributable to SLB - GAAP basis $735 $786 $739 -6% -1% Diluted EPS - GAAP basis $0.49 $0.52 $0.50 -6% -2% Adjusted EBITDA* $2,067 $1,899 $2,061 9% - Adjusted EBITDA margin* 21.9% 21.2% 23.1% 71 bps -121 bps Pretax segment operating income* $1,576 $1,404 $1,626 12% -3% Pretax segment operating margin* 16.7% 15.6% 18.2% 104 bps -153 bps Net income attributable to SLB, excluding charges & credits* $962 $833 $1,027
EZVIZ’s Smart Entry Solutions Have Consecutively Clinched the European Product Design Award and the Golden Pin Design Award, Indicating a Shift From Home Security to Living Enjoyment23.10.2026 11:58:00 CEST | Press Release
EZVIZ’s smart lock and AI-powered doorbell remained in the spotlight after IFA for bagging two world-class awards. The EP8 Ultra AI-powered video doorbell won the European Product Design Award 2026 (EPDA 2026), keeping leading in user-centric AI. Meanwhile, the DL50FVX smart lock was named the 2026 Golden Pin Design Award (GPDA) laureate for its intuitive access management and entered the finalist of the Best Design Awards. The growing prestige of EZVIZ’s smart home access management lineup marks a new chapter of providing living experiences with multi-level interaction, modern aesthetics, and emotional care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022441786/en/ Two representative models from EZVIZ's smart entry family take home prestigious awards for user-centric innovation. Founded in 2016, the EPDA aims to recognize well-thought-out products that break with tradition and improve everyday life. Continually refres
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines23.10.2026 07:00:00 CEST | Press Release
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the company’s Injectable Aesthetics portfolio in China – one of the world's largest and fastest-growing aesthetics markets.8,9 This approval follows successful authorizations and launches of Relfydess in more than 35 markets worldwide. Relfydess is the first and only ready-to-use liquid neuromodulator developed with PEARL Technology, designed to deliver a highly active, innovative, complex-free molecule that addresses the real needs of patients and healthcare professionals.1,2,4,5 It is optimized for simple volumetric dosing, without reconstitution, to increase ease-of-use and help ensure consistent dose/volume every time.1,10 At a time whenpatients and healthcare professionals are increasingly seeking high-performance neuromodulators that rapidly deliver long-lasting, natural-looking outcomes, Re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom